Aspire Biopharma Holdings, Inc.

Aspire Biopharma Holdings, Inc., trading under the ticker PWUP, is a blank-check company operating in the healthcare and biopharmaceutical sector. The company filed an 8-K current report with the Securities and Exchange Commission on August 10, 2026, under accession number 0001493152-26-036777, disclosing a material corporate event. PWUP conducted its initial public offering as a special purpose acquisition company targeting opportunities within the life sciences and biopharma industry. The filing reflects ongoing post-IPO activity as the company navigates its SPAC lifecycle. For complete filing details, sponsor information, deal status, and real-time SPAC analytics on PWUP and hundreds of other transactions, sign up for full data access at SpacDesk.